Antibiotic Stewardship
12
3
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study)
Reducing Overuse of Antibiotics at Discharge Home
Vancomycin Reduction Practices (VRP) in the NICU
BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
The DETOURS Trial: De-escalating Empiric Treatment: Opting Out of Rx for Selected Patients With Suspected Sepsis - Opt-Out Protocol Trial
Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis
Antibiotic Usage Prior to OnabotulinumtoxinA Injection
Early Neutropenic Fever De-escalation of Antibiotics Study
FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
Antibiotic Stewardship in Small Hospitals